Atlas Trials

Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal Transplantation

Clinical trial NCT05187455 · UNKNOWN

Trial details

NCT number
NCT05187455
Sponsor
Guangzhou General Hospital of Guangzhou Military Command
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Pharmacokinetics
Start date
2022-01-05
Primary completion
2022-11-30
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.